RAQUEL DECAMP: Open Payments
NPI 1215913512 · AUSTELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 16 payments from 8 companies in 2025. Trend: 2023 $1,007 · 2024 $1,077 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| HEARTFLOW, INC. | 2 | $120 |
| Novo Nordisk Inc | 4 | $84 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| PFIZER INC. | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Merck Sharp & Dohme LLC | 2 | $28 |
| Amgen Inc. | 1 | $23 |
Products named: FFRct, Wegovy, CAMZYOS, ELIQUIS, Kerendia, Ozempic, LEQVIO, VERQUVO.
Industry payments across GA — which companies pay providers there.
